Skip to content

Company information lookup

ACTINOGEN LIMITED (ACW)

Commercialisation of bioactive compounds

On this page you will find:

Delayed share price
Company announcements
Price history chart
Exchange Traded Options
ASX-Listed Emblem Company details
Closing prices
Dividends
Warrants & Structured Products

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
ACW 0.038 0% 0.035 0.038 0.000 0.000 0.000 0

ACTINOGEN LIMITED details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code ACW
Securities
Official Listing Date 16 October, 2007
GICS Industry Group Materials
Exempt Foreign? No
Internet Address http://www.actinogen.com.au
Registered Office Address Level 10, 15-17 Young Street, SYDNEY, NSW, AUSTRALIA, 2000
Head Office Telephone +61 2 9251 5620
Head Office Fax + 61 8 9321 1204
Share Registry AUTOMIC REGISTRY SERVICES
LEVEL 1, 7 VENTNOR AVENUE, WEST PERTH, WA, AUSTRALIA, 6005
Share Registry Telephone (08) 9324 2099
Directors / Senior Management
Mr Martin Rogers (Non Exec. Chairman)
Dr Bill Ketelbey (Managing Director, CEO)
Dr Jason Loveridge (Non Exec. Director)
Dr Anton Uvarov (Non Exec. Director)
Company Secretary Mr Peter Webse
Principal Activities Commercialisation of bioactive compounds

ACTINOGEN LIMITED announcements

How are company announcements published on www.asx.com.au?

Date Price
sens.
Headline Pages PDF
18/12/2014   Final Director's Interest Notice 2 PDF
18/12/2014   Appendix 3X-Dr Bill Ketelbey 2 PDF
18/12/2014 asterix Actinogen Board Changes 1 PDF
15/12/2014   Section 708A Notice 1 PDF
15/12/2014   Appendix 3B 12 PDF
15/12/2014 asterix Actinogen Medical Appoints Dr Bill Ketelbey as CEO 3 PDF
08/12/2014   Details of Company Address 1 PDF
08/12/2014   Becoming a substantial holder 2 PDF
08/12/2014   Section 708A Notice 1 PDF
05/12/2014   Becoming a substantial holder 2 PDF

> search for past company announcements

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
18 Dec 2014 0.038 -5% 0.038 0.036 513,289
16 Dec 2014 0.040 0% 0.040 0.040 250,000
15 Dec 2014 0.040 0% 0.040 0.039 260,478
12 Dec 2014 0.040 -4.76% 0.040 0.040 100,000
11 Dec 2014 0.042 5% 0.042 0.038 309,522

* Volume of shares shown represents only those shares traded on ASX.

ACTINOGEN LIMITED price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security ACW. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security ACW

Warrants & Structured Products

No warrants & Structured Products are available over the security ACW